The complex G protein-coupled receptor kinase 2 (GRK2) interactome unveils new physiopathological targets.

Departamento de Biología Molecular and Centro de Biología Molecular Severo Ochoa (Consejo Superior de Investigaciones Científicas-Universidad Autónoma de Madrid), Universidad Autónoma, Madrid, Spain.
British Journal of Pharmacology (Impact Factor: 5.07). 06/2010; 160(4):821-32. DOI: 10.1111/j.1476-5381.2010.00727.x
Source: PubMed

ABSTRACT GRK2 is a ubiquitous member of the G protein-coupled receptor kinase (GRK) family that appears to play a central, integrative role in signal transduction cascades. GRKs participate together with arrestins in the regulation of G protein-coupled receptors (GPCR), a family of hundreds of membrane proteins of key physiological and pharmacological importance, by triggering receptor desensitization from G proteins and GPCR internalization, and also by helping assemble macromolecular signalosomes in the receptor environment acting as agonist-regulated adaptor scaffolds, thus contributing to signal propagation. In addition, emerging evidence indicates that GRK2 can phosphorylate a growing number of non-GPCR substrates and associate with a variety of proteins related to signal transduction, thus suggesting that this kinase could also have diverse 'effector' functions. We discuss herein the increasing complexity of such GRK2 'interactome', with emphasis on the recently reported roles of this kinase in cell migration and cell cycle progression and on the functional impact of the altered GRK2 levels observed in several relevant cardiovascular, inflammatory or tumour pathologies. Deciphering how the different networks of potential GRK2 functional interactions are orchestrated in a stimulus, cell type or context-specific way is critical to unveil the contribution of GRK2 to basic cellular processes, to understand how alterations in GRK2 levels or functionality may participate in the onset or development of several cardiovascular, tumour or inflammatory diseases, and to assess the feasibility of new therapeutic strategies based on the modulation of the activity, levels or specific interactions of GRK2.

  • [Show abstract] [Hide abstract]
    ABSTRACT: G protein-coupled receptor kinases (GRKs) are emerging as important integrative nodes in cell migration processes. Recent evidence links GRKs (particularly the GRK2 isoform) to the complex modulation of diverse aspects of cell motility. In addition to its well-established role in the desensitization of G protein-coupled receptors involved in chemotaxis, GRK2 can play an effector role in the organization of actin and microtubule networks and in adhesion dynamics, by means of novel substrates and transient interacting partners, such as the GIT1 scaffold or the cytoplasmic α-tubulin deacetylase histone deacetylase 6 (HDAC6). The overall effect of altering GRK levels or activity on chemotaxis would depend on how such different roles are integrated in a given cell type and physiological context, and may have relevant implications in inflammatory diseases or cancer progression.
    Current opinion in cell biology 04/2014; 27C:10-17. · 14.15 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Heart failure (HF) causes a tremendous burden on the worldwide healthcare system, affecting >23 million people. There are many cardiovascular disorders that contribute to the development of HF and multiple risk factors that accelerate its occurrence, but regardless of its underlying cause, HF is characterized by a marked decrease in myocardial contractility and loss of pump function. One biomarker molecule consistently shown to be upregulated in human HF and several animal models is G protein-coupled receptor kinase-2 (GRK2), a kinase originally discovered to be involved in G protein-coupled receptor desensitization, especially β-adrenergic receptors. Higher levels of GRK2 can impair β-adrenergic receptor-mediated inotropic reserve and its inhibition, or molecular reduction has shown to improve pump function in several animal models including a preclinical pig model of HF. Recently, nonclassical roles for GRK2 in cardiovascular disease have been described, including negative regulation of insulin signaling, a role in myocyte cell survival and apoptotic signaling, and it has been shown to be localized in/on mitochondria. These new roles of GRK2 suggest that GRK2 may be a nodal link in the myocyte, influencing both cardiac contractile function and cell metabolism and survival and contributing to HF independent of its canonical role in G protein-coupled receptor desensitization. In this review, classical and nonclassical roles for GRK2 will be discussed, focusing on recently discovered roles for GRK2 in cardiomyocyte metabolism and the effects that these roles may have on myocardial contractile function and HF development.
    Circulation Research 05/2014; 114(10):1661-70. · 11.86 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: G protein coupled receptor kinase 2 (GRK2) has a key role in cellular function by regulating different intracellular mechanisms in a kinase dependent or independent manner. In this review we have dealt with the recently discovered roles of GRK2 in the regulation of cell metabolism. In particular, we have focused on recent findings about the mitochondrial role of GRK2 in the regulation of energy metabolism. Few findings exist about this topic that all concur to identify a mitochondrial localization of GRK2, leading to the rising of the following question: is GRK2 detrimental or advantageous for mitochondrial function? By the review of available literature, a new concept arises about GRK2 role into the cell,which is that of a stress protein acutely activated by cellular stress whose specific subcellular localization, in particular mitochondrial localization, results in compensatory metabolic responses. Thus, the possibility to regulate GRK2 trafficking within the cell is a promising strategy to regulate the adaptative effects of the kinase on cell metabolism. I. G protein coupled receptor kinase 2 G protein coupled receptor kinases (GRK) family comprises seven serine/threonine kinases which phosphorylate and regulate G protein coupled receptors (GPCR) (1). GRKs share structural and functional similarities (2): a well-conserved central catalytic domain is flanked by N-terminal domain, that includes a region of homology to regulators of G-protein signaling (RH), with weak homology among the members of the different subfamilies, and C-terminal domain of variable length,which have little or no sequence homology(3, 4). GRKs have different tissue distribution, subcellular localization, and kinase activity regulation(5, 6). They mostly localize at the plasma membrane (7), but recently new subcellular localizations have been suggested for these kinases (5, 8, 9). GRK2 is known as a cytoplasmic protein that translocates to plasma membrane upon GPCR stimulation where it specifically recognizes and phosphorylates agonist-activated GPCRs leading to receptor desensitization (10, 11). Besides its effect on GPCR regulation, in the last decade GRK2 has been proposed as a multi-functional protein which is involved in the regulation of several cellular functions through the phosphorylation of cytosolic substrates or in a phosphorylation-independent manner through protein-protein interaction (12-18). Recently, new functions for this kinase have been evidenced in several conditions (cardiovascular, inflammatory diseases or cancer), characterized by increased levels of GRK2 (10, 19-21). Such a finding suggests that this kinase could be a potential interesting diagnostic marker and/or therapeutic target for many conditions. In this review we will discuss the role of GRK2 in energy metabolism and mitochondrial function.
    06/2014; 10.

Full-text (2 Sources)

Available from
Jun 5, 2014